Royce & Associates’s Ironwood Pharmaceuticals IRWD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $363K | Sell |
506,060
-229,376
| -31% | -$165K | ﹤0.01% | 738 |
|
|
2025
Q1 | $1.08M | Hold |
735,436
| – | – | 0.01% | 664 |
|
|
2024
Q4 | $3.26M | Buy |
735,436
+72,502
| +11% | +$321K | 0.03% | 553 |
|
|
2024
Q3 | $2.73M | Buy |
662,934
+64,353
| +11% | +$265K | 0.02% | 580 |
|
|
2024
Q2 | $3.9M | Buy |
598,581
+7,577
| +1% | +$49.4K | 0.04% | 526 |
|
|
2024
Q1 | $5.15M | Buy |
591,004
+292,241
| +98% | +$2.55M | 0.05% | 488 |
|
|
2023
Q4 | $3.42M | Buy |
298,763
+14,013
| +5% | +$160K | 0.03% | 568 |
|
|
2023
Q3 | $2.74M | Buy |
284,750
+2,130
| +0.8% | +$20.5K | 0.03% | 604 |
|
|
2023
Q2 | $3.01M | Sell |
282,620
-1,603,627
| -85% | -$17.1M | 0.03% | 601 |
|
|
2023
Q1 | $19.8M | Buy |
1,886,247
+210,758
| +13% | +$2.22M | 0.2% | 136 |
|
|
2022
Q4 | $20.8M | Sell |
1,675,489
-2,722
| -0.2% | -$33.7K | 0.22% | 119 |
|
|
2022
Q3 | $17.4M | Buy |
1,678,211
+184,574
| +12% | +$1.91M | 0.2% | 134 |
|
|
2022
Q2 | $17.2M | Buy |
1,493,637
+332,791
| +29% | +$3.84M | 0.18% | 151 |
|
|
2022
Q1 | $14.6M | Buy |
1,160,846
+679,997
| +141% | +$8.55M | 0.12% | 241 |
|
|
2021
Q4 | $5.61M | Buy |
+480,849
| New | +$5.61M | 0.04% | 539 |
|
|
2020
Q3 | – | Sell |
-2,328
| Closed | -$24K | – | 1078 |
|
|
2020
Q2 | $24K | Buy |
2,328
+463
| +25% | +$4.77K | ﹤0.01% | 1108 |
|
|
2020
Q1 | $19K | Buy |
+1,865
| New | +$19K | ﹤0.01% | 1092 |
|